The 88th PHARMCHINA ends successfully, we look forward to meeting again

On May 15, the 88th PHARMCHINA was grandly opened in Shanghai National Convention and Exhibition Center. The theme of the   PHARMCHINA is “Building a New Ecology of Pharmaceutical Health Innovation and Inclusion”. The scale of the PHARMCHINA reaches 170,000 square meters, nearly 4,000 domestic and foreign well-known enterprises from more than 20 countries and regions are concentrated, and the participating audience reaches nearly 150,000 people!

As a comprehensive pharmaceutical enterprise integrating R&D, production and sales, our company was invited to participate in the 88th PHARMCHINA , and set up a 36 square meters special booth in the Chemical Pharmaceutical Pavilion, Booth No. 72C10. The company 's brand image and key products such as Amoxicillin (Amoxicillin Capsules), C&O^® (Ketan Mixture), Lulite^®; (Luliconazole Cream) and Aoboping^®; (Rabeprazole Sodium for Injection) were displayed. At this PHARMCHINA, core products such as C&O^®; (Ketan Mixture) and Lulite^®; (Luliconazole Cream) have attracted the attention and favor of many customers and participants.

During the 88th PHARMCHINA, customers from all over the country came in droves. All staff of our company, accurately and professionally transfer product information, core selling points and cooperation value points, etc., deeply analyze our product characteristics and market advantages with customers, and promote the establishment of cooperative relations. Many senior customers stopped to inquire and expressed positive cooperation intention. This PHARMCHINA not only deepens the close ties with existing partners, but also attracts many new partners, laying a solid foundation for future cooperation.

In the future, Ping An Shionogi Co., Ltd. C&O Pharmaceutical is willing to join hands with more industry partners to discuss the prospects and plan for the future, and work together with all parties to improve the health of the majority of patients and enhance the quality of life, and look forward to bringing the gospel to more patients.